NASDAQ:HOWL | Free Cash Flow | Werewolf Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$10.6M
2025-12-31-$11.02M$0.00-$11.02M
2025-03-31-$18.95M$0.00-$18.95M
2024-12-31-$14.25M$123,000.00-$14.38M
2024-03-31-$15.3M$111,000.00-$15.41M
2023-12-31-$4.59M$198,000.00-$4.78M
2023-03-31-$9.9M$168,000.00-$10.07M
2022-12-31-$11.87M$518,000.00-$12.39M
2022-03-31-$13.95M$28,000.00-$13.98M
2021-12-31-$12.67M$272,000.00-$12.95M
2021-03-31-$7.33M$13,000.00-$7.34M
2020-12-31-$6.01M$9,000.00-$6.02M
2020-03-31-$3.4M$449,000.00-$3.85M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$60.29M$0.00-$60.29M
2024-12-31-$56.19M$254,000.00-$56.44M
2023-12-31-$32.61M$769,000.00-$33.38M
2022-12-31-$40.6M$3.61M-$44.21M
2021-12-31-$42.88M$498,000.00-$43.37M
2020-12-31-$18.62M$560,000.00-$19.18M